About Neuralocity

Neuralocity LLC builds a molecule data platform for early drug discovery. We package computationally generated and curated molecules into searchable, versioned opportunity sets — pre-screened and ranked by target-class fit, safety risk, drug-likeness, novelty, and synthesis readiness — delivered as licensed datasets with provenance and export workflows.

What we do

Discovery teams spend too much time narrowing enormous chemical spaces into practical screening lists. Neuralocity compresses that work: customers browse a catalog of novel molecules with multi-dimensional annotations, evaluate curated opportunity sets, build shortlists, and export licensed data for downstream computational and laboratory validation.

Our scoring emphasizes target-class relevance — kinase-like, GPCR-like, protease-like — expressed as within-catalog ranks and percentiles, not surrogate assay potency claims. That framing keeps the product scientifically defensible and suitable for research-use licensing.

Who we serve

• Computational chemists at early-stage biotechs triaging compound lists
• Medicinal chemists evaluating shortlists for synthesis and ordering
• Discovery program leads who need defensible starting pools for partnering discussions
• CRO and academic teams that need focused molecule sets without building a full screening pipeline

How we are different

• Novel molecule supply from an internal generative pipeline, not aggregation of public catalogs alone
• Target-class intelligence with publishable methodology and provenance per catalog release
• Multi-dimensional safety overlay applied at catalog scale
• Licensed opportunity sets as the commercial unit — CSV export with audit logging and entitlement controls

Contact

Questions about Neuralocity, licensing, or pilots may be sent to contact@neuralocity.com.